{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:01:55Z","timestamp":1740106915773,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00277-018-3349-y","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T23:23:05Z","timestamp":1525994585000},"page":"1317-1325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin\u2019s lymphomas: evidence from a meta-analysis"],"prefix":"10.1007","volume":"97","author":[{"given":"Yi-shu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8238-7194","authenticated-orcid":false,"given":"Zheng-tao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"3349_CR1","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/00001622-200209000-00009","volume":"14","author":"O Martinez-Maza","year":"2002","unstructured":"Martinez-Maza O, Breen EC (2002) B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol 14:528\u2013532","journal-title":"Curr Opin Oncol"},{"key":"3349_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","volume":"59","author":"J Peveling-Oberhag","year":"2013","unstructured":"Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S (2013) Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 59:169\u2013177. https:\/\/doi.org\/10.1016\/j.jhep.2013.03.018","journal-title":"J Hepatol"},{"key":"3349_CR3","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1158\/0008-5472.CAN-12-1639","volume":"72","author":"AJ Roos De","year":"2012","unstructured":"De Roos AJ, Mirick DK, Edlefsen KL et al (2012) Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma. Cancer Res 72:4733\u20134743. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1639","journal-title":"Cancer Res"},{"key":"3349_CR4","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/ijc.29969","volume":"138","author":"FS Hosnijeh","year":"2016","unstructured":"Hosnijeh FS, Portengen L, Spath F et al (2016) Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: a nested case-control study and meta-analyses. Int J Cancer 138:2357\u20132367. https:\/\/doi.org\/10.1002\/ijc.29969","journal-title":"Int J Cancer"},{"key":"3349_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imm.12586","volume":"148","author":"D Perez-Witzke","year":"2016","unstructured":"Perez-Witzke D, Miranda-Garcia MA, Suarez N et al (2016) CTLA4Fcepsilon, a novel soluble fusion protein that binds B7 molecules and the IgE receptors, and reduces human in vitro soluble CD23 production and lymphocyte proliferation. Immunology 148:40\u201355. https:\/\/doi.org\/10.1111\/imm.12586.","journal-title":"Immunology"},{"key":"3349_CR6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1182\/blood.V71.1.94.94","volume":"71","author":"M Sarfati","year":"1988","unstructured":"Sarfati M, Bron D, Lagneaux L, Fonteyn C, Frost H, Delespesse G (1988) Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. Blood 71:94\u201398","journal-title":"Blood"},{"key":"3349_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.imlet.2011.08.004","volume":"141","author":"B Platzer","year":"2011","unstructured":"Platzer B, Ruiter F, van der Mee J, Fiebiger E (2011) Soluble IgE receptors\u2014elements of the IgE network. Immunol Lett 141:36\u201344. https:\/\/doi.org\/10.1016\/j.imlet.2011.08.004","journal-title":"Immunol Lett"},{"key":"3349_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2249.2010.04210.x","volume":"162","author":"M Acharya","year":"2010","unstructured":"Acharya M, Borland G, Edkins AL, MacLellan LM, Matheson J, Ozanne BW, Cushley W (2010) CD23\/FcepsilonRII: molecular multi-tasking. Clin Exp Immunol 162:12\u201323. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04210.x.","journal-title":"Clin Exp Immunol"},{"key":"3349_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1365-2257.2006.00750.x","volume":"28","author":"B Saka","year":"2006","unstructured":"Saka B, Aktan M, Sami U, Oner D, Sanem O, Dincol G (2006) Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia. Clin Lab Haematol 28:30\u201335. https:\/\/doi.org\/10.1111\/j.1365-2257.2006.00750.x","journal-title":"Clin Lab Haematol"},{"key":"3349_CR10","first-page":"310","volume":"81","author":"V Callea","year":"1996","unstructured":"Callea V, Morabito F, Luise F, Piromalli A, Filangeri M, Stelitano C, Iacopino P, Nobile F, Brugiatelli M (1996) Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia. Haematologica 81:310\u2013315","journal-title":"Haematologica"},{"key":"3349_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0145-2126(90)90145-Y","volume":"14","author":"M Sarfati","year":"1990","unstructured":"Sarfati M, Fournier S, Christoffersen M, Biron G (1990) Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. Leuk Res 14:47\u201355","journal-title":"Leuk Res"},{"key":"3349_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3109\/10428199709058320","volume":"27","author":"WU Knauf","year":"1997","unstructured":"Knauf WU, Langenmayer I, Ehlers B, Mohr B, Adorf D, Nerl CH, Hallek M, Zwingers TH, Emmerich B, Thiel E (1997) Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia. Leuk Lymphoma 27:523\u2013532. https:\/\/doi.org\/10.3109\/10428199709058320","journal-title":"Leuk Lymphoma"},{"key":"3349_CR13","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/1055-9965.EPI-14-1107","volume":"24","author":"R Kaaks","year":"2015","unstructured":"Kaaks R, Sookthai D, Luczynska A et al (2015) Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23. Cancer Epidemiol Biomark Prev 24:538\u2013545. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-1107","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3349_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"3349_CR15","unstructured":"GA Wells, B Shea, D O'Connell, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"3349_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"3349_CR17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1158\/1055-9965.EPI-11-0037","volume":"20","author":"EC Breen","year":"2011","unstructured":"Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, Kaslow RA, Variakojis D, Bream JH, Rinaldo CR, Ambinder RF, Martinez-Maza O (2011) B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Cancer Epidemiol Biomark Prev 20:1303\u20131314","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3349_CR18","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1158\/1055-9965.EPI-13-0614","volume":"22","author":"SK Hussain","year":"2013","unstructured":"Hussain SK, Hessol NA, Levine AM, Breen EC, Anastos K, Cohen M, D'Souza G, Gustafson DR, Silver S, Martinez-Maza O (2013) Serum biomarkers of immune activation and subsequent risk of non-Hodgkin B cell lymphoma among hiv-infected women. Cancer Epidemiol Biomark Prev 22:2084\u20132093","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3349_CR19","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/leu.2015.2","volume":"29","author":"MP Purdue","year":"2015","unstructured":"Purdue MP, Lan Q, Kemp TJ, Hildesheim A, Weinstein SJ, Hofmann JN, Virtamo J, Albanes D, Pinto LA, Rothman N (2015) Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma. Leukemia 29:1429\u20131431","journal-title":"Leukemia"},{"key":"3349_CR20","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-16-2345","volume":"77","author":"F Spath","year":"2017","unstructured":"Spath F, Wibom C, Krop EJM et al (2017) Biomarker dynamics in B-cell lymphoma: a longitudinal prospective study of plasma samples up to 25 years before diagnosis. Cancer Res 77:1408\u20131415","journal-title":"Cancer Res"},{"key":"3349_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2010.06.008","volume":"133","author":"S Veeranki","year":"2010","unstructured":"Veeranki S, Choubey D (2010) Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins. Immunol Lett 133:1\u20135. https:\/\/doi.org\/10.1016\/j.imlet.2010.06.008","journal-title":"Immunol Lett"},{"key":"3349_CR22","doi-asserted-by":"publisher","unstructured":"Glauzy S, Boccitto M, Bannock JM, et al. Antigen-driven lymphoproliferations in Sjogren\u2019s Syndrome patients accumulate in complement receptor 2\/CD21(\u2212\/low) B cells. Arthritis Rheumatol 2017. doi: https:\/\/doi.org\/10.1002\/art.40352 .","DOI":"10.1002\/art.40352"},{"key":"3349_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/COH.0000000000000327","volume":"12","author":"MS Shiels","year":"2017","unstructured":"Shiels MS, Engels EA (2017) Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS 12:6\u201311. https:\/\/doi.org\/10.1097\/COH.0000000000000327","journal-title":"Curr Opin HIV AIDS"},{"key":"3349_CR24","first-page":"243","volume":"21","author":"B Gottsche","year":"1988","unstructured":"Gottsche B, Salama A, Mueller-Eckhardt C (1988) Acute autoimmune hemolytic anemia in childhood caused by Donath-Landsteiner antibodies. Beitr Infusionsther 21:243\u2013246","journal-title":"Beitr Infusionsther"},{"key":"3349_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/QAI.0b013e31829d4d50","volume":"64","author":"Y Guo","year":"2013","unstructured":"Guo Y, Siewe B, Epeldegui M, Detels R, Landay AL, Martinez-Maza O (2013) TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis. J Acquir Immune Defic Syndr 64:204\u2013210. https:\/\/doi.org\/10.1097\/QAI.0b013e31829d4d50","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3349_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/08820139.2010.534218","volume":"40","author":"ZQ Yao","year":"2011","unstructured":"Yao ZQ, Ni L, Zhang Y, Ma CJ, Zhang CL, Dong ZP, Frazier AD, Wu XY, Thayer P, Borthwick T, Chen XY, Moorman JP (2011) Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin\u2019s lymphoma. Immunol Investig 40:243\u2013264. https:\/\/doi.org\/10.3109\/08820139.2010.534218","journal-title":"Immunol Investig"},{"key":"3349_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/clim.1999.4782","volume":"93","author":"D Widney","year":"1999","unstructured":"Widney D, Gundapp G, Said JW, van der Meijden M, Bonavida B, Demidem A, Trevisan C, Taylor J, Detels R, Mart\u0131\u0301nez-Maza O (1999) Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin Immunol 93:114\u2013123. https:\/\/doi.org\/10.1006\/clim.1999.4782","journal-title":"Clin Immunol"},{"key":"3349_CR28","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/ijc.29637","volume":"137","author":"BA Bassig","year":"2015","unstructured":"Bassig BA, Shu XO, Koh WP, Gao YT, Purdue MP, Butler LM, Adams-Haduch J, Xiang YB, Kemp TJ, Wang R, Pinto LA, Zheng T, Ji BT, Hosgood HD, Hu W, Yang G, Zhang H, Chow WH, Kim C, Seow WJ, Zheng W, Yuan JM, Lan Q, Rothman N (2015) Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts. Int J Cancer 137:2688\u20132695. https:\/\/doi.org\/10.1002\/ijc.29637","journal-title":"Int J Cancer"},{"key":"3349_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/1055-9965.EPI-12-1122","volume":"22","author":"SK Hussain","year":"2013","unstructured":"Hussain SK, Zhu W, Chang SC, Breen EC, Vendrame E, Magpantay L, Widney D, Conn D, Sehl M, Jacobson LP, Bream JH, Wolinsky S, Rinaldo CR, Ambinder RF, Detels R, Zhang ZF, Martinez-Maza O (2013) Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk. Cancer Epidemiol Biomark Prev 22:295\u2013307. https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-1122","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3349_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10875-012-9766-0","volume":"33","author":"DE Ouedraogo","year":"2013","unstructured":"Ouedraogo DE, Makinson A, Kuster N, Nagot N, Rubbo PA, Bollore K, Foulongne V, Cartron G, Olive D, Reynes J, Vendrell JP, Tuaillon E (2013) Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patients. J Clin Immunol 33:22\u201329. https:\/\/doi.org\/10.1007\/s10875-012-9766-0","journal-title":"J Clin Immunol"},{"key":"3349_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0065-2776(08)60776-2","volume":"49","author":"G Delespesse","year":"1991","unstructured":"Delespesse G, Suter U, Mossalayi D et al (1991) Expression, structure, and function of the CD23 antigen. Adv Immunol 49:149\u2013191","journal-title":"Adv Immunol"},{"key":"3349_CR32","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.4049\/jimmunol.138.8.2576","volume":"138","author":"K Yukawa","year":"1987","unstructured":"Yukawa K, Kikutani H, Owaki H et al (1987) A B cell-specific differentiation antigen, CD23, is a receptor for IgE (Fc epsilon R) on lymphocytes. J Immunol 138:2576\u20132580","journal-title":"J Immunol"},{"key":"3349_CR33","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1182\/blood.V85.7.1843.bloodjournal8571843","volume":"85","author":"S Yawetz","year":"1995","unstructured":"Yawetz S, Cumberland WG, van der Meyden M, Martinez-Maza O (1995) Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome\u2014associated non-Hodgkin\u2019s lymphoma. Blood 85:1843\u20131849","journal-title":"Blood"},{"key":"3349_CR34","first-page":"281","volume":"12","author":"AS Bansal","year":"1994","unstructured":"Bansal AS, MacGregor AJ, Pumphrey RS, Silman AJ, Ollier WE, Wilson PB (1994) Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Clin Exp Rheumatol 12:281\u2013285","journal-title":"Clin Exp Rheumatol"},{"key":"3349_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1081\/JAS-200044761","volume":"42","author":"DJ Amrol","year":"2005","unstructured":"Amrol DJ, Hagaman DD, Sheller JR, Murray JJ (2005) Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge. J Asthma 42:73\u201376","journal-title":"J Asthma"},{"key":"3349_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/978-3-319-22822-8_13","volume":"390","author":"JA Healy","year":"2015","unstructured":"Healy JA, Dave SS (2015) The role of EBV in the pathogenesis of diffuse large B cell lymphoma. Curr Top Microbiol Immunol 390:315\u2013337. https:\/\/doi.org\/10.1007\/978-3-319-22822-8_13","journal-title":"Curr Top Microbiol Immunol"},{"key":"3349_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ijc.28971","volume":"136","author":"LR Teras","year":"2015","unstructured":"Teras LR, Rollison DE, Pawlita M, Michel A, Brozy J, de Sanjose S, Blase JL, Gapstur SM (2015) Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies. Int J Cancer 136:108\u2013116. https:\/\/doi.org\/10.1002\/ijc.28971","journal-title":"Int J Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3349-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T15:16:05Z","timestamp":1693667765000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3349-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["3349"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3349-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2018,5,11]]},"assertion":[{"value":"3 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}